TY  - GEN
AU  - Offidani,Massimo
AU  - Corvatta,Laura
AU  - Centurioni,Riccardo
AU  - Leoni,Franco
AU  - Malerba,Lara
AU  - Mele,Anna
AU  - Marconi,Monica
AU  - Scortechini,Annarita
AU  - Masia,M Cristiana
AU  - Leoni,Pietro
TI  - High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia
SN  - 1466-4860
PY  - 2003///0717
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Betamethasone
KW  - Bone Marrow Diseases
KW  - chemically induced
KW  - Burkitt Lymphoma
KW  - drug therapy
KW  - Comorbidity
KW  - Cyclophosphamide
KW  - Cytarabine
KW  - Daunorubicin
KW  - Disease-Free Survival
KW  - Drug Carriers
KW  - Female
KW  - Follow-Up Studies
KW  - Granulocyte Colony-Stimulating Factor
KW  - therapeutic use
KW  - Humans
KW  - Infections
KW  - etiology
KW  - Leukemia, T-Cell
KW  - Life Tables
KW  - Liposomes
KW  - Male
KW  - Methotrexate
KW  - Middle Aged
KW  - Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
KW  - Prospective Studies
KW  - Remission Induction
KW  - Safety
KW  - Survival Analysis
KW  - Topotecan
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1038/sj.thj.6200222
ER  -